Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries

Journal of Virology

Volumn 73, Issue 7, 1999, Pages 5795-5802

  Ferrer, Marc ^a   Harrison, Stephen C ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; LIGAND; MONOCLONAL ANTIBODY 17B; NEUTRALIZING ANTIBODY; PEPTIDE; PEPTIDE LIBRARY; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING COMPETITION; BINDING SITE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; LIGAND BINDING; NONHUMAN; PEPTIDE ANALYSIS; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN INTERACTION; VIRUS CELL INTERACTION; VIRUS INHIBITION;

EID: 0033027065     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.7.5795-5802.1999     Document Type: Article

References (40)

1. Brodsky, M. H., M. Warton, R. M. Myers, and D. R. Littman. 1990. Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J. Immunol. 144:3078-3086.
2. Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1994. Structure of influenza haemaglutinin at the pH of membrane fusion. Nature 371:37-43.
3. Carr, C. M., and P. S. Kim. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823-832.
4. Chan, D. C., D. Fass, J. M. Berger, and P. S. Kim. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273.
5. Dormán, G., and G. D. Prestwich. 1994. Benzophenone photophores in biochemistry. Biochemistry 33:5661-5673.
6. Ferrer, M., K. L. Godbout, B. J. Sullivan, D. A. Austen, C. T. Sanderson, K. C. Kelley, M. S. Osburne, S. C. Harrison, and M. R. van Schravendijk. 1997. Construction and characterization of a radio-iodinatable mutant of recombinant human CD4. J. Immunol. Methods 210:215-225.
7. Ferrer, M., B. J. Sullivan, K. L. Godbout, E. Burke, H. S. Stump, J. Godoy, A. Golden, A. T. Profy, and M. R. van Schravendidjk. Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120. J. Pept. Res., in press.
8. Ferrer, M. Unpublished results.
9. Furuta, R A., C. T. Wild, Y. Weng, and C. D. Weiss. 1998. Capture of an early fusion-active conformation of HIV-1 gp41. Nat. Struct. Biol. 5:276-279.
10. Gizachew, D., D. B. Moffett, S. C. Busse, W. M. Westler, E. A. Dratz, and M. Teintze. 1998. NMR studies on the conformation of the CD4 36-59 peptide bound to HIV-1 gp120. Biochemistry 37:10616-10625.
11. Hughson, F. M. 1997. Enveloped viruses: a common mode of membrane fusion? Curr. Biol. 7:565-569.
12. Jameson, B. A., P. E. Rao, L. I. Kong, B. H. Hahn, G. M. Shaw, L. E. Hood, and S. B. H. Kent. 1988. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science 240:1335-1339.
13. Kilby J. M., S. Hopkins, T. M. Venetta, B. DiMassimo, G. A. Cloud, J. Y. Lee, L. Alldredge, E. Hunter, D. Lambert, D. Bolognesi, T. Matthews, M. R. Johnson, M. A. Nowak, G. M. Shaw, and M. S. Saag. 1998. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4:1302-1307.
14. Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
15. Lawless, M. K., S. Barney, K. I. Guthrie, T. B Bucy, S. R. Petteway, and G Merutka. 1996. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry 35:13697-13708.
16. Lifson, J. D., K. M. Hwang, P. L. Nara, B. Fraser, M. Padgett, N. M. Dunlop, and L. E. Eiden. 1988. Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. Science 241:712-716.
17. Littman, D. R. 1998. Chemokine receptors: keys to AIDS pathogenesis? Cell 93:677-680.
18. Moebius, U., L. K. Clayton, S. Abraham, A. Diener, J. J. Yunis, S. C. Harrison, and E. L. Reinherz. 1992. Human immunodeficiency virus gp120 binding C′C″ ridge of CD4 domain 1 is also involved in interactions with class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:12008-12012.
19. Moebius, U., L. K. Clayton, S. Abraham, S. C. Harrison, and E. L. Reinherz. 1992. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure. J. Exp. Med. 176:507-517.
20. Moore, J. P., L. A. Wallace, E. A. C. Follett, and J. A. McKeating. 1989. An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. AIDS 3:155-163.
21. Rapoport, I., Y. C. Chen, P. Cupers, S. E. Shoelson, and T. Kirchhausen. 1998. Dileucine-based sorting signals bind to the β chain of AP-1 at a site distinct and regulated differently from the tyrosine-based motif-binding site. EMBO J. 17:2148-2155.
22. Repke, H., D. Gabuzda, G. Palú, F. Emmrich, and J. Sodroski. 1992. Effects of CD4 synthetic peptides on HIV type 1 envelope glycoprotein function. J. Immunol. 149:1809-1816.
23. Rizzuto, C. D., R. Wyatt, N. Hernández-Ramos, Y. Sun, P. D. Kwong, W. A. Hendrickson, and J. Sodroski. 1998. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 288:1949-1953.
24. Sattentau, Q. J., J. Arthos, D. K. N. Hanna, D. Healey, P. C. Beverly, R. Sweet, and A. Truneh. 1989. Structural analysis of the human immunodeficiency virus-binding domain of CD4. J. Exp. Med. 170:1319-1334.
25. Sattentau, Q. J., and J. P. Moore. 1993. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67:7383-7393.
26. Sattentau, Q. J, and J. P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-415.
27. Schockmel, G. A., C. Somoza, S. J. Davis, A. F. Williams, and D. Healey. 1992. Construction of a binding site for human immunodeficiency virus Type 1 gp12c0 in rat CD4. J. Exp. Med. 175:301-304.
28. Simon, J. H. M., C. Somoza, G. A. Schockmel, M. Collin, S. J. Davis, A. F. Williams, and W. James. 1993. A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection. J. Exp. Med. 177:949-954.
29. Smith, G. P., and V. A. Petrenko. 1997. Phage display. Chem. Rev. 97:391-410.
30. Sullivan, N., Y. Sun, Q. Sattentau, M. Thali, D. Wu, G. Denisova, J. Gershoni, J. Robinson, J. Moore, and J. Sodroski. 1998. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 72:4694-4703.
31. Tan, K., J.-H. Liu, J.-H. Wang, S. Shen, and M. Lu. 1997. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl. Acad. Sci. USA 94: 12303-12308.
32. Thali, M., J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski, 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978-3988.
33. Trkola, A, T. Dragic, J. Arthos, J. M. Binley, W. C. Olson, G. P. Allaway, C. Cheng-Mayer, J. Robinson, P. J. Maddon, and J. P. Moore. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384:184-187.
34. Weissenhorn, W., A. Dessen, S. C. Harrison, J. J. Skehel, and D. C. Wiley. 1997. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387: 426-430.
35. Wild, C., J. W. Dubay, T. Greenwell, T. Baird, T. G. Oas, C. McDanal, E. Hunter, and T. Matthews. 1994. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA 91:12676-12680.
36. Wild, C., T. Oas, C. McDanal, D. Bolognesi, and T. Matthews. 1992. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89:10537-10541.
37. Wild, C. T., D. C. Shugars, T. K. Greenwell, C. B. McDanal, and T. J. Matthews. 1994. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91:9770-9774.
38. Wrighton, N. C., F. X. Farrell, R. Chang, A. K. Kashyap, F. P. Barbone, L. S. Mulcahy, D. L. Johnson, R. W. Barrett, L. K. Jolliffe, and W. J. Dower. 1996. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273:458-463.
39. Wu, H., D. G. Myszka, S. W. Tendian, C. G. Brouillette, R. W. Sweet, I. M. Chaiken, and W. A. Hendrickson. 1996. Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding. Proc. Natl. Acad. Sci. USA 93:15030-15035.
40. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A. A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183.